InflaRx NV (IFRX)
1.015
0.00 (0.00%)
USD |
NASDAQ |
Dec 30, 15:47
InflaRx Market Cap: 68.76M for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CDT Equity, Inc. | 2.134M |
| LENZ Therapeutics, Inc. | 503.14M |
| Liminatus Pharma, Inc. | 17.51M |
| Oruka Therapeutics, Inc. | 1.387B |
| Maze Therapeutics, Inc. | 1.928B |
Market Cap Related Metrics
| PS Ratio | 313.62 |
| PEG Ratio | -0.1673 |
| Price to Book Value | 1.290 |
| Price | 1.015 |
| Earnings Yield | -90.31% |
| PEGY Ratio | -0.1673 |